Phyllis Wachsberger

TitleAsst Professor
InstitutionThomas Jefferson University
DepartmentRadiation Oncology
Address111 S. 11th Street
Philadelphia PA 19107
Phone215-955-5238
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wachsberger PR, Lawrence YR, Liu Y, Rice B, Feo N, Leiby B, Dicker AP. Hsp90 inhibition enhances PI-3 kinase inhibition and radiosensitivity in glioblastoma. J Cancer Res Clin Oncol. 2014 Apr; 140(4):573-82. PMID: 24500492.
      Citations:    
    2. Wachsberger PR, Lawrence RY, Liu Y, Rice B, Daskalakis C, Dicker AP. Epidermal growth factor receptor mutation status and rad51 determine the response of glioblastoma to multimodality therapy with cetuximab, temozolomide, and radiation. Front Oncol. 2013; 3:13. PMID: 23383403.
      Citations:    
    3. Wachsberger PR, Lawrence RY, Liu Y, Xia X, Andersen B, Dicker AP. Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic. J Neurooncol. 2011 Nov; 105(2):181-90. PMID: 21516367.
      Citations:    
    4. Wachsberger PR, Lawrence YR, Liu Y, Daroczi B, Xu X, Dicker AP. Epidermal growth factor receptor expression modulates antitumor efficacy of vandetanib or cediranib combined with radiotherapy in human glioblastoma xenografts. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):483-91. PMID: 21095630.
      Citations:    
    5. Wachsberger P, Burd R, Ryan A, Daskalakis C, Dicker AP. Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model. Int J Radiat Oncol Biol Phys. 2009 Nov 1; 75(3):854-61. PMID: 19801101.
      Citations:    
    6. Yan K, Wachsberger P, Yu Y. Acoustic radiation force and optical spectroscopy for assessing tumor vessel normalization during anti-angiogenic therapy. Conf Proc IEEE Eng Med Biol Soc. 2009; 2009:769-72. PMID: 19964240.
      Citations:    
    7. Yan K, Wachsberger P, Yu Y. Investigation of acoustic radiation force for radio-protecting normal tissues during radiation therapy. Conf Proc IEEE Eng Med Biol Soc. 2009; 2009:2304-7. PMID: 19965172.
      Citations:    
    8. Burd R, Wachsberger P. Application of radiotherapy and chemotherapy protocols to pre-clinical tumor models. Curr Protoc Pharmacol. 2007 Sep; Chapter 14:Unit 14.7. PMID: 21948166.
      Citations:    
    9. Wachsberger PR, Burd R, Cardi C, Thakur M, Daskalakis C, Holash J, Yancopoulos GD, Dicker AP. VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma. Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1526-37. PMID: 17234361.
      Citations:    
    10. Thangasamy T, Sittadjody S, Lanza-Jacoby S, Wachsberger PR, Limesand KH, Burd R. Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase. Nutr Cancer. 2007; 59(2):258-68. PMID: 18001220.
      Citations:    
    11. Cantor JP, Iliopoulos D, Rao AS, Druck T, Semba S, Han SY, McCorkell KA, Lakshman TV, Collins JE, Wachsberger P, Friedberg JS, Huebner K. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer. 2007 Jan 1; 120(1):24-31. PMID: 17019711.
      Citations:    
    12. Wachsberger PR, Burd R, Marero N, Daskalakis C, Ryan A, McCue P, Dicker AP. Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):835-42. PMID: 15701874.
      Citations:    
    13. Wachsberger P, Burd R, Dicker AP. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways. Hematol Oncol Clin North Am. 2004 Oct; 18(5):1039-57, viii. PMID: 15474334.
      Citations:    
    14. Thakur ML, Coss R, Howell R, Vassileva-Belnikolovska D, Liu J, Rao SP, Spana G, Wachsberger P, Leeper DL. Role of lipid-soluble complexes in targeted tumor therapy. J Nucl Med. 2003 Aug; 44(8):1293-300. PMID: 12902421.
      Citations:    
    15. Wachsberger P, Burd R, Dicker AP. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin Cancer Res. 2003 Jun; 9(6):1957-71. PMID: 12796357.
      Citations:    
    16. Burd R, Lavorgna SN, Daskalakis C, Wachsberger PR, Wahl ML, Biaglow JE, Stevens CW, Leeper DB. Tumor oxygenation and acidification are increased in melanoma xenografts after exposure to hyperglycemia and meta-iodo-benzylguanidine. Radiat Res. 2003 Mar; 159(3):328-35. PMID: 12600235.
      Citations:    
    Wachsberger's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (128)
    Explore
    _
    Co-Authors (5)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _